FDA Adverse Event Injury Summary report: N

ALARIS PCA MODULE

MDR report key: 3981490 · Received July 25, 2014

Report

Report Number
2016493-2014-00352
Event Type
Injury
Date Received
July 25, 2014
Date of Event
June 24, 2014
Report Date
June 26, 2014
Manufacturer
CAREFUSION CORP.
Product Code
MEA
PMA / PMN Number
K032233
Removal / Correction Number
NA
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
CA, US
Reporter Occupation
PHARMACIST

Narratives

Additional Manufacturer Narrative · 1

(B)(4). DEVICES NOT RECEIVED, LOG REVIEW ONLY. THE EVENT LOGS HAVE BEEN RECEIVED AND THE EVALUATION IS PENDING. A FOLLOW UP REPORT WILL BE SUBMITTED WITH INVESTIGATION RESULTS ONCE THE EVALUATION HAS BEEN COMPLETED.

Description of Event or Problem · 1

THE CUSTOMER REPORTED THAT A PATIENT RECEIVING A PCA INFUSION DESATURATED AND CODED. INITIALLY POST-OP THE PATIENT WAS ON DILAUDID PCA FOR 2 HOURS BUT WAS NOT RECEIVING RELIEF. AT APPROXIMATELY 9 PM THE INFUSION WAS CHANGED TO MORPHINE 30 MG/30 ML WITH NO BASAL RATE, PCA DOSE 2 MG, 6 MINUTE LOCKOUT, MAX LIMIT 12 MG/HR. (THE INITIAL ORDER HAD BEEN FOR A MAX LIMIT OF 20 MG/HR BUT THE PHARMACIST CALLED THE PHYSICIAN TO ADJUST IT AS THE PHARMACIST FELT THAT WAS TOO HIGH A LIMIT.) THE PATIENT WAS DOING WELL UNTIL AROUND MIDNIGHT WHEN SHE DETERIORATED AND REQUIRED RESUSCITATION. THE MORPHINE WAS STOPPED AND THE PATIENT WAS INTUBATED AND WAS NOT DOING WELL AFTER THE EVENT. THE CUSTOMER REQUESTS AN EVENT LOG REVIEW FOR A POSSIBLE OVER INFUSION.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
436976 ALARIS PCA MODULE PCA INFUSION DEVICE MEA CAREFUSION CORP. 8120 NA

Patients

Seq Age Sex Outcome Treatment
1 71 YR Required Intervention ALARIS ETCO2 MODULE, SN (B)(4)| ALARIS PUMP MODULE, SN (B)(4)| EXTENSION SET, MANUFACTURER/MODEL/LOT UNK| ALARIS PUMP MODULE TUBING, MODEL/LOT UNK| IMS 30 ML SYRINGE, MODEL/LOT UNK| ALARIS PC UNIT, SN (B)(4)